Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07290530) titled '24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome' on Dec. 16, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Nacuity Pharmaceuticals, Inc.
Condition:
Retinitis Pigmentosa (RP)
Usher Syndrome
Intervention:
Drug: N-acetylcysteine amide
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: June 2026
Target Sample Size: 80
To ...